249 related articles for article (PubMed ID: 23361282)
1. Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies.
Gupta S; Sodhani P; Jain S
J Cancer Res Ther; 2012; 8(4):602-9. PubMed ID: 23361282
[TBL] [Abstract][Full Text] [Related]
2. Malignancies in Pleural, Peritoneal, and Pericardial Effusions.
Dermawan JKT; Policarpio-Nicolas ML
Arch Pathol Lab Med; 2020 Sep; 144(9):1086-1091. PubMed ID: 31913661
[TBL] [Abstract][Full Text] [Related]
3. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and categorization of malignant effusions: A 6-year review from a single academic institution.
Lew M; Cantley R; Heider A; Jing X
Diagn Cytopathol; 2021 May; 49(5):615-621. PubMed ID: 32275354
[TBL] [Abstract][Full Text] [Related]
5. Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis.
Gupta P; Pandey T; Gautam U; Rajwanshi A; Srinivasan R; Gupta N; Rohilla M; Varma N; Dey P
Diagn Cytopathol; 2021 May; 49(5):647-656. PubMed ID: 33629825
[TBL] [Abstract][Full Text] [Related]
6. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
Saab J; Hoda RS; Narula N; Hoda SA; Geraghty BE; Nasar A; Alperstein SA; Port JL; Giorgadze T
Cancer Cytopathol; 2017 Feb; 125(2):128-137. PubMed ID: 28207201
[TBL] [Abstract][Full Text] [Related]
8. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
9. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
[TBL] [Abstract][Full Text] [Related]
10. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
11. Identifying the primary site of malignancy in carcinomatous serous effusions using immunocytochemistry.
Kundu R; Parwaiz A; Gupta P; Rohilla M; Gupta N; Srinivasan R; Dey P
Cytopathology; 2022 Nov; 33(6):678-687. PubMed ID: 35749049
[TBL] [Abstract][Full Text] [Related]
12. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
Sears D; Hajdu SI
Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
[TBL] [Abstract][Full Text] [Related]
13. Bull's eye (target) inclusions in neoplastic cells in malignant serous effusions. A study of 289 cases.
Kumar PV; Eqbali S; Monabati A; Talei AR
Acta Cytol; 2000; 44(4):543-6. PubMed ID: 10934946
[TBL] [Abstract][Full Text] [Related]
14. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology.
Sundling KE; Cibas ES
Cancer Cytopathol; 2018 Aug; 126 Suppl 8():590-598. PubMed ID: 30156768
[TBL] [Abstract][Full Text] [Related]
15. Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusions.
Ascoli V; Taccogna S; Scalzo CC; Nardi F
Diagn Cytopathol; 1995 Jun; 12(4):303-8. PubMed ID: 7656755
[TBL] [Abstract][Full Text] [Related]
16. Adult granulosa cell tumor presenting as metastases to the pleural and peritoneal cavity.
Gupta N; Rajwanshi A; Dey P; Suri V
Diagn Cytopathol; 2012 Oct; 40(10):912-5. PubMed ID: 21618710
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
Ang PP; Tan GC; Karim N; Wong YP
Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
[TBL] [Abstract][Full Text] [Related]
18. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
[TBL] [Abstract][Full Text] [Related]
19. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
20. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology.
Sahu S; Gupta P; Susheilia S; Gautam U; Dey P
Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]